BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31177216)

  • 1. Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives.
    Wharton W; Zhao L; Steenland K; Goldstein FC; Schneider JA; Barnes LL; Gearing M; Yasar S
    J Alzheimers Dis; 2019; 70(1):153-161. PubMed ID: 31177216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I
    J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
    Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
    Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mutual Self- and Informant-Report of Cognitive Complaint Correlates with Neuropathological Outcomes in Mild Cognitive Impairment.
    Gifford KA; Liu D; Hohman TJ; Xu M; Han X; Romano RR; Fritzsche LR; Abel T; Jefferson AL
    PLoS One; 2015; 10(11):e0141831. PubMed ID: 26539829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Alzheimer-type lesions in cognitively normal subjects.
    Tsartsalis S; Xekardaki A; Hof PR; Kövari E; Bouras C
    Neurobiol Aging; 2018 Feb; 62():34-44. PubMed ID: 29107845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.
    Tremblay C; François A; Delay C; Freland L; Vandal M; Bennett DA; Calon F
    J Neuropathol Exp Neurol; 2017 Feb; 76(2):70-88. PubMed ID: 28158844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired glycemia increases disease progression in mild cognitive impairment.
    Morris JK; Vidoni ED; Honea RA; Burns JM;
    Neurobiol Aging; 2014 Mar; 35(3):585-9. PubMed ID: 24411018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.
    Tan CH; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Dillon WP; Bonham LW; Yokoyama JS; Karch CM; Brewer JB; Rabinovici GD; Miller BL; Schellenberg GD; Kauppi K; Feldman HA; Holland D; McEvoy LK; Hyman BT; Bennett DA; Andreassen OA; Dale AM; Desikan RS;
    Acta Neuropathol; 2018 Jan; 135(1):85-93. PubMed ID: 29177679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.
    Wharton W; Goldstein FC; Tansey MG; Brown AL; Tharwani SD; Verble DD; Cintron A; Kehoe PG
    J Alzheimers Dis; 2018; 61(2):815-824. PubMed ID: 29254080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric Inventory-Assessed Nighttime Behavior Accompanies, but Does Not Precede, Progressive Cognitive Decline Independent of Alzheimer's Disease Histopathology.
    Atayde AL; Fischer CE; Schweizer TA; Munoz DG
    J Alzheimers Dis; 2020; 74(3):839-850. PubMed ID: 32116249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.
    Sabbagh MN; Cooper K; DeLange J; Stoehr JD; Thind K; Lahti T; Reisberg B; Sue L; Vedders L; Fleming SR; Beach TG
    Curr Alzheimer Res; 2010 Jun; 7(4):280-6. PubMed ID: 19715548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.
    Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J
    Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Che S; Elarova I; Chen Y; Jeanneteau F; Kranz TM; Chao MV; Counts SE; Mufson EJ
    Hippocampus; 2019 May; 29(5):422-439. PubMed ID: 28888073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
    Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
    J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of neuropathologic changes in the cerebral cortex of centenarians.
    Giannakopoulos P; Hof PR; Vallet PG; Giannakopoulos AS; Charnay Y; Bouras C
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):577-92. PubMed ID: 8588057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.